BioLineRx Ltd. BLRX

$ 0.28 -14.77%

Annual report 2023
added 11-23-2024

BioLineRx Ltd. Financial Statements 2011-2024 | BLRX

Annual Financial Statements BioLineRx Ltd.

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	-	-	1.35 B	42.5 M	22 M	47.8 M	98.1 M	59 M	52.9 M	58.4 M	65.7 M	77.1 M	47.1 M
Shares	-	-	663 M	16.9 M	9.76 M	7.24 M	6 M	3.74 M	3.43 M	2.16 M	1.5 M	1.13 M	824 K
Historical Prices	0.72	1.37	2.04	2.52	2.25	6.6	16.4	13.8	19.5	24.3	42.1	38	47.5
Net Income	-	-	-27.1 M	-30 M	-25.4 M	-23 M	-24.4 M	-15.8 M	-14.4 M	-10.2 M	-17.6 M	-20.4 M	-13.2 M
Revenue	4.8 M	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-	-24.8 M	-22.9 M	-28.1 M	-25.6 M	-25.2 M	-16.5 M	-16.2 M	-	-	-	-
Interest Expense	2.14 M	1.79 M	984 K	1.47 M	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-24.8 M	-22.9 M	-28.1 M	-25.6 M	-25.2 M	-16.5 M	-16.2 M	-15.8 M	-17.5 M	-21.8 M	-15 M
Operating Expenses	-	-	-	-	28.1 M	25.6 M	25.2 M	16.5 M	16.2 M	15.9 M	17.6 M	21.8 M	15.4 M
General and Administrative Expenses	-	-	4.31 M	3.84 M	3.37 M	3.87 M	3.57 M	3.47 M	3.22 M	3.06 M	3.33 M	3.23 M	3.34 M

All numbers in USD currency

Quarterly Income Statement BioLineRx Ltd.

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	-	-	-	-	-	-	669 M	-	-	-	220 M	-	-	-	145 M	-	-	-	107 M	-	-	-	94.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-	-	-	-	-	-	-6.84 M	-	-	-	-6.77 M	-	-	-	-5.48 M	-	-	-	-4.79 M	-	-	-	-4.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-	-	-	-	-	-6.51 M	-	-	-	-5.57 M	-	-	-	-6.48 M	-	-	-	-5.73 M	-	-	-	-5.19 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-6.51 M	-	-	-	-5.57 M	-	-	-	-6.48 M	-	-	-	-5.73 M	-	-	-	-5.19 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	-	-	-	-	-	-	1.04 M	-	-	-	744 K	-	-	-	949 K	-	-	-	883 K	-	-	-	844 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency